Unlock instant, AI-driven research and patent intelligence for your innovation.

cgas-sting pathway activators and their uses

A pathway, cell technology, applied in the field of activators, which can solve the problem of unclear identification and clearance

Active Publication Date: 2022-07-19
PEKING UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The free DNA present in the cytoplasm of the cell will be regarded as a potential danger signal by the host's innate immune system, but the mechanism by which the immune system recognizes and clears these danger signals is still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • cgas-sting pathway activators and their uses
  • cgas-sting pathway activators and their uses
  • cgas-sting pathway activators and their uses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0118] Example 1.Mn 2+ Treatment confers resistance to viral infection in host cells

[0119] Experiment (a)

[0120] with 100 μM MnCl 2THP1 cells cultured in RPMI-1640 medium (Gibco) supplemented with 10% FBS were pretreated for 12 hours, and then treated with HSV-1-GFP (obtained from Chinese Academy of Medical Sciences) at MOI of 0.5, VSV-GFP (obtained from Cells were infected from Rongbin zhou, University of Science and Technology of China) or NDV-GFP (obtained from Chen Wang, Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences). After 24 hours, cells were photographed and measured using flow cytometry (FACSCalibur) and analyzed using FlowJo (eg figure 1 shown). figure 1 The use of Mn is clearly shown in 2+ Pretreatment confers resistance to viral infection in host cells.

[0121] As mentioned above, with figure 2 or image 3 MnCl at the indicated concentrations 2 THP1 cells were treated with either DMXAA (DMX) for 24 hours, then cells were inf...

Embodiment 2

[0128] Example 2. Intravenous injection of Mn 2+ confer virus resistance in mice

[0129] Experiment (a)

[0130] Take eight-week-old SPF grade C57BL / 6 (purchased from Beijing Weitong Lihua Co., Ltd.), mix liquid A and liquid B (as described above) according to the ratio in the table, and inject through tail vein. 16-24 hours later, herpes simplex virus type I (HSV-1), vesicular stomatitis virus (VSV) type of New Jersey and vaccinia virus (VacV) were injected, respectively. Virus titers in mice were detected using the plaque assay after 48 hours, and virus lethality was monitored.

[0131] Table 2. Intravenous injection of Mn 2+ Virus titers in mice

[0132] A liquid liquid B Mncl 2 Usage amount

HSV-1 titer VSV titer VacV titer 200μL 0μL 0mg / kg 198μL 2μL 1mg / kg 196μL 4μL 2mg / kg 190μL 10μL 5mg / kg drop hundreds of times 180μL 20μL 10mg / kg drop hundreds of times

[0133] Ta...

Embodiment 3

[0139] Example 3.Mn 2+ Effects of treatment on downstream gene expression

[0140] Experiment (a)

[0141] with 100 μM MnCl 2 THP1 cells were treated for 12 hours with , VACV, IFNβ or medium (control), RNA was extracted and sequenced. By calculating log 2 ((treated RPKM) / (control RPKM)) to obtain a heat map of gene expression (eg Image 6 shown in A).

[0142] Experiment (b)

[0143] with 200 μM MnCl 2 THP1 cells were treated and discarded after 2, 12, 24 hours containing MnCl 2 The medium and replaced with fresh medium, NW means that the MnCl-containing medium is not discarded 2 culture medium, Image 6 B shows the production of I-IFN.

[0144] Experiment (c)

[0145] With the indicated concentrations of MnCl 2 , Mn(OAc) 2 or Mn(OAc) 3 THP1 cells were treated for 24 hours, then supernatants were analyzed using an I-IFN bioassay, Image 6 C shows that treatment with different manganese salts induces I-IFN production, indicating that both divalent manganese salts...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a new type of activator of cGAS-STING pathway and the use of the activator for activating cGAS-STING pathway. The present invention also provides the use of the activator for improving innate immunity and / or adaptive immunity.

Description

technical field [0001] The present invention provides a new class of activators of the cGAS-STING pathway and the use of the activators for activating the cGAS-STING pathway. The present invention also provides the use of the activator for improving innate immunity and / or adaptive immunity. Background technique [0002] The innate immune system plays a crucial role in resisting infection, inhibiting tumor growth and the pathogenesis of autoimmune diseases. It mainly recognizes components of pathogenic microorganisms and cancer cells through pattern recognition receptors, initiates downstream signaling pathways, and finally induces Cytokine expression, on the one hand, kills pathogenic microorganisms and infected or cancerous cells, and on the other hand activates the acquired immune system to promote the production of antibodies and specific T lymphocytes, thereby protecting the body from pathogenic microorganisms and tumors . [0003] Specifically, the innate immune syste...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K33/32A61K39/39A61K45/06A61P37/04A61P43/00A61P31/04A61P31/14A61P31/20A61P31/18A61P31/22A61P3/10A61P17/06A61P19/02A61P37/02A61P35/00A61P33/02A61P33/12A61P33/06
CPCA61K39/39A61K45/06A61K33/32A61K2039/55505Y02A50/30
Inventor 蒋争凡管玉坤王晨光
Owner PEKING UNIV